Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue: +38.3%
EPS: −294.7%
Free cash flow: +5.09%
Total debt: +40.8%

Quarter to June 2026, against a year earlier

24.11 2.55 −9.56%

Follow HIMS

Alert me

Market cap: $5.6B
P/E: 0.0×
Fwd P/E: −49.4×
Dividend yield: —
F-score: 4/9
Altman Z: 4.10
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Hims & Hers Health, Inc. (HIMS) P/E ratio

Alert me on P/E ratio

Hims & Hers Health, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 496× (December 2019) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/HIMS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Hims &amp; Hers Health, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/HIMS/metrics/pe-ratio">Hims &amp; Hers Health, Inc. (HIMS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	57.0×	36.64%
FY2024	41.7×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2020	198×	0.00%
FY2019	198×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	57.0×	(39.74%)
Sep 2025	94.5×	66.88%
22 more quarters	Free account

Against its own ten years

Low 0.0× High 496×

Ten-year median 0.0×

Current reading's percentile 68

Company	P/E ratio
HIMS Hims & Hers Health, Inc.	n/m
AMLX Amylyx Pharmaceuticals, Inc. compare	n/m
ALKS Alkermes plc compare	n/m
SUPN Indivior Pharmaceuticals Inc. compare	7.6×
LNTH Lantheus Holdings, Inc. compare	24.3×
LQDA Liquidia Corporation compare	28.5×
AMRX AMNEAL PHARMACEUTICALS, INC. compare	36.9×
RDY Dr. Reddy's Laboratories Ltd compare	44.4×
KNSA Kiniksa Pharmaceuticals International, plc compare	62.1×
Drug Manufacturers Specialty & Generic industry median	20.5×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Hims & Hers Health, Inc. (HIMS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on HIMS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on HIMS

Stockrow Weekly